ADRB2 and breast carcinoma: Therefore, more data on the interplay between PTHrP and β2-AR in breast cancer bone metastasis are urgently required, since this knowledge could change our understanding of the dynamics of β2-AR expression in bone throughout the progression of this disease and facilitate the design of new, more effective therapeutic options.